Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers Tenders > Headlines for 2013 > News item |
Israel's Teva Pharmaceutical calls $500 million 5.55% notes due 2016
By Tali David
Minneapolis, March 1 - Teva Pharmaceutical Industries Ltd. finance subsidiary Teva Pharmaceutical Finance Co., LLC called its roughly $500 million of 5.55% senior notes due 2016, according to a press release.
The notes will be redeemed at par plus a make-whole premium and accrued interest from Feb. 1 on March 22.
The redemption is being funded with cash on hand.
Teva is a Petach Tikva, Israel-based pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.